{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:05:20Z","timestamp":1791295520533,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1136\/ard.2002.004796","type":"journal-article","created":{"date-parts":[[2004,6,11]],"date-time":"2004-06-11T17:48:16Z","timestamp":1086976096000},"page":"831-835","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction"],"prefix":"10.1016","volume":"63","author":[{"given":"M","family":"Bijl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Bootsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"van der Geld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P C","family":"Limburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C G M","family":"Kallenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M H","family":"van Rijswijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2002.004796_bib1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1365-2249.1994.tb06594.x","article-title":"Binding of pentraxins to different nuclear structures: C-reactive protein binds to small nuclear ribonucleoprotein particles, serum amyloid P component binds to chromatin and nucleoli","volume":"97","author":"Pepys","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard.2002.004796_bib2","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1182\/blood.V96.13.4300","article-title":"The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells","volume":"96","author":"Rovere P , Peri","year":"2000","journal-title":"Blood"},{"key":"10.1136\/ard.2002.004796_bib3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/278259a0","article-title":"Serum amyloid P-component is an acute-phase reactant in the mouse","volume":"278","author":"Pepys","year":"1979","journal-title":"Nature"},{"key":"10.1136\/ard.2002.004796_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1084\/jem.172.1.13","article-title":"Pentraxin-chromatin interactions: serum amyloid P component specifically displaces H1-type histones and solubilizes native long chromatin","volume":"172","author":"Butler","year":"1990","journal-title":"J Exp Med"},{"key":"10.1136\/ard.2002.004796_bib5","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1084\/jem.192.9.1353","article-title":"C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an anti-inflammatory innate immune response. Implications for systemic autoimmunity","volume":"192","author":"Gershov D , Kim","year":"2000","journal-title":"J Exp Med"},{"key":"10.1136\/ard.2002.004796_bib6","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1023\/A:1026478914129","article-title":"Complexes of serum amyloid P component and DNA in serum from healthy individuals and systemic lupus erythematosus patients","volume":"20","author":"Sorensen","year":"2000","journal-title":"J Clin Immunol"},{"key":"10.1136\/ard.2002.004796_bib7","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.4049\/jimmunol.166.2.1200","article-title":"Serum amyloid P component and C-reactive protein mediate phagocytosis through murine Fc gamma Rs","volume":"166","author":"Mold C , Gresham","year":"2001","journal-title":"J Immunol"},{"key":"10.1136\/ard.2002.004796_bib8","doi-asserted-by":"crossref","first-page":"647","DOI":"10.4049\/jimmunol.167.2.647","article-title":"Chromatin-independent binding of serum amyloid P component to apoptotic cells","volume":"167","author":"Familian A , Zwart","year":"2001","journal-title":"J Immunol"},{"key":"10.1136\/ard.2002.004796_bib9","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1084\/jem.179.4.1317","article-title":"Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes","volume":"179","author":"Casciola-Rosen","year":"1994","journal-title":"J Exp Med"},{"key":"10.1136\/ard.2002.004796_bib10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.iy.10.040192.001411","article-title":"Apoptosis and programmed cell death in immunity","volume":"10","author":"Cohen","year":"1992","journal-title":"Annu Rev Immunol"},{"key":"10.1136\/ard.2002.004796_bib11","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ng0598-56","article-title":"Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies","volume":"19","author":"Botto M , Dell\u2019Agnola","year":"1998","journal-title":"Nat Genet"},{"key":"10.1136\/ard.2002.004796_bib12","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/9544","article-title":"Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity","volume":"5","author":"Bickerstaff","year":"1999","journal-title":"Nat Med"},{"key":"10.1136\/ard.2002.004796_bib13","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1046\/j.1365-3083.2002.01178.x","article-title":"Structural, quantitative and functional comparison of amyloid P component in sera from patients with systemic lupus erythematosus and healthy donors","volume":"56","author":"Sen","year":"2002","journal-title":"Scand J Immunol"},{"key":"10.1136\/ard.2002.004796_bib14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1191\/096120398678919804","article-title":"High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus","volume":"7","author":"Perniok A , Wedekind","year":"1998","journal-title":"Lupus"},{"key":"10.1136\/ard.2002.004796_bib15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/ard.58.5.309","article-title":"Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded, DNA, and neutropenia","volume":"58","author":"Courtney","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2002.004796_bib16","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2002.004796_bib17","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/art.1780330505","article-title":"Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study","volume":"33","author":"ter Borg","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2002.004796_bib18","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","article-title":"A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE","volume":"35","author":"Bombardier C , Gladman","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2002.004796_bib19","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","article-title":"The American College of Rheumatology 1990 criteria for the classification of Wegener\u2019s granulomatosis","volume":"33","author":"Leavitt","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2002.004796_bib20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2002.004796_bib21","first-page":"883","article-title":"Serum matrix metalloproteinase 3 levels during treatment with sulfasalazine or combination of methotrexate and sulfasalazine in patients with early rheumatoid arthritis","volume":"29","author":"Posthumus","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2002.004796_bib22","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/0140-6736(90)92205-V","article-title":"Prevention of relapses in Wegener\u2019s granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre","volume":"336","author":"Tervaert","year":"1990","journal-title":"Lancet"},{"key":"10.1136\/ard.2002.004796_bib23","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1681\/ASN.V9101915","article-title":"Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glomerulonephritis","volume":"9","author":"Franssen","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1136\/ard.2002.004796_bib24","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1080\/003655201750163132","article-title":"Recombinant human interleukin-6 induces hepatocyte growth factor production in cancer patients","volume":"36","author":"de Jong","year":"2001","journal-title":"Scand J Gastroenterol"},{"key":"10.1136\/ard.2002.004796_bib25","first-page":"284","article-title":"Binding of serum amyloid P-component (SAP) by amyloid fibrils","volume":"38","author":"Pepys","year":"1979","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard.2002.004796_bib26","first-page":"633","article-title":"Serum amyloid P-component levels in amyloidosis, connective tissue diseases, infection, and malignancy as compared to normal serum","volume":"94","author":"Skinner M , Vaitukaitis","year":"1979","journal-title":"J Lab Clin Med"},{"key":"10.1136\/ard.2002.004796_bib27","first-page":"153","article-title":"Protein SAP (serum amyloid P-component) in Waldenstrom\u2019s macroglobulinaemia, multiple myeloma and rheumatic diseases","volume":"8","author":"Strachan","year":"1982","journal-title":"J Clin Lab Immunol"},{"key":"10.1136\/ard.2002.004796_bib28","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1084\/jem.188.2.387","article-title":"Systemic exposure to irradiated apoptotic cells induces autoantibody production","volume":"188","author":"Mevorach D , Zhou","year":"1998","journal-title":"J Exp Med"},{"key":"10.1136\/ard.2002.004796_bib29","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1681\/ASN.V1281764","article-title":"Rats injected with syngenic rat apoptotic neutrophils develop antineutrophil cytoplasmic antibodies","volume":"12","author":"Patry","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1136\/ard.2002.004796_bib30","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/art.10737","article-title":"Serum amyloid P component binds to late apoptotic cells and mediates their uptake by monocyte-derived macrophages","volume":"48","author":"Bijl M , Horst","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2002.004796_bib31","first-page":"1642","article-title":"C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: a prospective longitudinal study","volume":"17","author":"ter Borg","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2002.004796_bib32","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-2249.1992.tb05840.x","article-title":"Plasma concentration of IL-6 in systemic lupus erythematosus; an indicator of disease activity?","volume":"90","author":"Spronk","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard.2002.004796_bib33","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/ard.51.3.358","article-title":"Patients with systemic lupus erythematosus and Jaccoud\u2019s arthropathy: a clinical subset with an increased C reactive protein response?","volume":"51","author":"Spronk","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2002.004796_bib34","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1002\/1529-0131(200112)44:12<2841::AID-ART472>3.0.CO;2-6","article-title":"PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation","volume":"44","author":"Fazzini F , Peri","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2002.004796_bib35","first-page":"129","article-title":"Elevated anti-serum amyloid P component (SAP) antibodies in SLE patients [abstract]","volume":"61","author":"Zandman-Goddard G , Blank","year":"2002","journal-title":"Ann Rheum Dis"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724185305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724185305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2002.004796","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T13:36:48Z","timestamp":1736084208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724185305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S0003496724185305"],"URL":"https:\/\/doi.org\/10.1136\/ard.2002.004796","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2002.004796","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Copyright 2004 by Annals of the Rheumatic Diseases. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}